|
[1]
|
World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization; 2023. https://www.who.int/publications/i/item/9789240083851. |
|
[2]
|
World Health Organization. WHO consolidated guidelines on tuberculosis: module 2: screening: systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021. https://www.who.int/publications/i/item/9789240022676. |
|
[3]
|
Dhana A, Gupta RK, Hamada Y, Kengne AP, Kerkhoff AD, Yoon C, et al. Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis. Eur Respir Rev 2023;32(168):230021. https://doi.org/10.1183/16000617.0021-2023CrossRef
|
|
[4]
|
Yoon C, Chaisson LH, Patel SM, Allen IE, Drain PK, Wilson D, et al. Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis. Int J Tuberc Lung Dis 2017;21(9):1013 − 9. https://doi.org/10.5588/ijtld.17.0078CrossRef
|
|
[5]
|
Meyer AJ, Ochom E, Turimumahoro P, Byanyima P, Sanyu I, Lalitha R, et al. C-reactive protein testing for active tuberculosis among inpatients without HIV in Uganda: a diagnostic accuracy study. J Clin Microbiol 2020;59(1):e02162 − 20. https://doi.org/10.1128/JCM.02162-20CrossRef
|
|
[6]
|
Saripalli A, Ramapuram J. C-reactive protein as a screening test for tuberculosis in people living with HIV in southern India: a cross-sectional, observational study. J Clin Med 2022;11(13):3566. https://doi.org/10.3390/jcm11133566CrossRef
|
|
[7]
|
Shapiro AE, Hong T, Govere S, Thulare H, Moosa MY, Dorasamy A, et al. C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa. AIDS 2018;32(13):1811. https://doi.org/10.1097/QAD.0000000000001902CrossRef
|
|
[8]
|
Yoon C, Semitala FC, Atuhumuza E, Katende J, Mwebe S, Asege L, et al. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study. Lancet Infect Dis 2017;17(12):1285 − 92. https://doi.org/10.1016/S1473-3099(17)30488-7CrossRef
|
|
[9]
|
Calderwood CJ, Reeve BWP, Mann T, Palmer Z, Nyawo G, Mishra H, et al. Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults. J Infect 2023;86(1):24 − 32. https://doi.org/10.1016/j.jinf.2022.10.041CrossRef
|
|
[10]
|
Kagujje M, Mwanza W, Somwe P, Chilukutu L, Creswell J, Muyoyeta M. Sensitivity and specificity of CRP and symptom screening as tuberculosis screening tools among HIV-positive and negative outpatients at a primary healthcare facility in Lusaka, Zambia: a prospective cross-sectional study. BMJ Open 2023;13(4):e061907. https://doi.org/10.1136/bmjopen-2022-061907CrossRef
|